,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2012-05-08 05:16:00,"Chicago, IL - May 8, 2012 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.01959409937262535,0.008273246698081493,0.9721326231956482,neutral,0.011320852674543858
1,2012-05-08 05:16:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2012-05-08 05:16:00,"Stocks recently featured in the blog include Colgate-Palmolive Company ( CL ), Procter & Gamble Company ( PG ), JP Morgan Chase & Company ( JPM ), Citigroup Inc. ( C ) and Morgan Stanley ( MS ).",0.01995893567800522,0.008891589008271694,0.9711495041847229,neutral,0.011067346669733524
3,2012-05-08 05:16:00,"Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Monday's Analyst Blog:

In an effort to enhance its financial flexibility and focus on future growth prospects, one of the leading global consumer product manufacturers Colgate-Palmolive Company ( CL ) has recently sold $500 million worth of 10-year medium-term notes, Reuters reported.",0.5896399021148682,0.00894591212272644,0.401414155960083,positive,0.5806939601898193
4,2012-05-08 05:16:00,"According to news, the new medium-term notes have been issued at $98.249 with a coupon rate of 2.30% maturing in May, 2022.",0.041842490434646606,0.004758552648127079,0.9533988833427429,neutral,0.0370839387178421
5,2012-05-08 05:16:00,The coupon rate is believed to be the lowest 10-year coupon rate and ties with Procter & Gamble Company 's ( PG ) 10-year medium-term notes maturing in March 2022.,0.02975854091346264,0.7023305296897888,0.2679108679294586,negative,-0.6725720167160034
6,2012-05-08 05:16:00,"Moreover, the company will use the fund to retire its old commercial paper.",0.06847356259822845,0.006186044309288263,0.9253404140472412,neutral,0.06228751689195633
7,2012-05-08 05:16:00,"Financed by a consortium of investment bankers, JP Morgan Chase & Company ( JPM ), Citigroup Inc. ( C ) and Morgan Stanley ( MS ), the funds will be used to retire its old commercial paper.",0.15708006918430328,0.005820063408464193,0.8370998501777649,neutral,0.15126000344753265
8,2012-05-08 05:16:00,"At the end of fiscal 2011, Colgate has total domestic and foreign outstanding commercial paper worth $671 million.",0.018638014793395996,0.01218809187412262,0.9691739082336426,neutral,0.0064499229192733765
9,2012-05-08 05:16:00,"Borrowing costs have gone down significantly, marking a record low, and in turn, facilitating the companies to obtain easy financing at compelling prices.",0.6901922225952148,0.22831501066684723,0.0814928188920021,positive,0.4618772268295288
10,2012-05-08 05:16:00,"Corporate bonds are in high demand as U.S. treasuries are yielding low rates, driving investors toward the bonds issued by the sound companies.",0.3920930325984955,0.26266080141067505,0.3452461361885071,positive,0.12943223118782043
11,2012-05-08 05:16:00,"Debt offers of big companies are being oversubscribed, providing the corporation the option to price their offerings at lower rates.",0.07072661072015762,0.3997778296470642,0.5294955372810364,neutral,-0.3290512263774872
12,2012-05-08 05:16:00,"Hence, several companies are coming up with debt offerings to generate interest expense savings by refinancing their outstanding borrowings.",0.7581300139427185,0.011821100488305092,0.23004885017871857,positive,0.7463089227676392
13,2012-05-08 05:16:00,Colgate-Palmolive is the industry leader in oral care and commands market-leading positions in several personal care product categories.,0.7083925008773804,0.010837726294994354,0.2807697355747223,positive,0.6975547671318054
14,2012-05-08 05:16:00,"Furthermore, a strong portfolio of globally recognized brands, including Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Elmex, Ajax and Axion provide a competitive advantage to the company and strengthens its dominant position in the market.",0.9454280138015747,0.015580754727125168,0.03899119049310684,positive,0.929847240447998
15,2012-05-08 05:16:00,"Moreover, we believe Colgate-Palmolive's continued focus on innovation and development of new products will facilitate it in enhancing its customer base while increasing market share.",0.9471435546875,0.015236062929034233,0.03762034699320793,positive,0.9319074749946594
16,2012-05-08 05:16:00,"The company is focusing on acquiring businesses, which have the potential to generate higher top-line growth and margin.",0.8416624665260315,0.010498229414224625,0.14783933758735657,positive,0.8311642408370972
17,2012-05-08 05:16:00,We believe the company's recent acquisition and divestment transactions will boost its bottom line.,0.9483716487884521,0.014814844354987144,0.03681351616978645,positive,0.9335567951202393
18,2012-05-08 05:16:00,"However, Colgate-Palmolive operates in an intensely competitive environment.",0.7163612842559814,0.01682502217590809,0.266813725233078,positive,0.6995362639427185
19,2012-05-08 05:16:00,The resurgence of archrival Procter & Gamble has signaled new challenges.,0.834223747253418,0.034530702978372574,0.13124559819698334,positive,0.7996930480003357
20,2012-05-08 05:16:00,"Global competitive conditions have also intensified, and Colgate is facing strong competition in China, Russia, India, Hong Kong, Brazil and Mexico.",0.9424185752868652,0.014488640241324902,0.043092742562294006,positive,0.9279299378395081
21,2012-05-08 05:16:00,"Currently, Colgate-Palmolive maintains a Zacks #3 Rank, which translates into a short-term Hold recommendation.",0.07664347440004349,0.010412768460810184,0.9129437208175659,neutral,0.06623070687055588
22,2012-05-08 05:16:00,Our long-term recommendation on the stock remains Neutral.,0.01976904459297657,0.02998259849846363,0.9502483606338501,neutral,-0.01021355390548706
23,2012-05-08 05:16:00,Want more from Zacks Equity Research?,0.041235875338315964,0.017298029735684395,0.9414660930633545,neutral,0.02393784560263157
24,2012-05-08 05:16:00,Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515 .,0.013104813173413277,0.015546849928796291,0.9713483452796936,neutral,-0.0024420367553830147
25,2012-05-08 05:16:00,Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.,0.06386703997850418,0.004654404241591692,0.9314785599708557,neutral,0.059212636202573776
26,2012-05-08 05:16:00,"Continuous coverage is provided for a universe of 1,150 publicly traded stocks.",0.036364275962114334,0.004866600502282381,0.9587691426277161,neutral,0.03149767592549324
27,2012-05-08 05:16:00,Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance.,0.054108913987874985,0.005191051866859198,0.9407000541687012,neutral,0.04891786351799965
28,2012-05-08 05:16:00,Recommendations and target prices are six-month time horizons.,0.013092893175780773,0.007127966266125441,0.9797791242599487,neutral,0.0059649269096553326
29,2012-05-08 05:16:00,"Zacks ""Profit from the Pros"" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research.",0.027419384568929672,0.007709485478699207,0.9648711085319519,neutral,0.01970990002155304
30,2012-05-08 05:16:00,"Subscribe to this free newsletter today: http://at.zacks.com/?id=5517

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks.",0.015577997080981731,0.00747905345633626,0.9769430160522461,neutral,0.008098943158984184
31,2012-05-08 05:16:00,As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results.,0.7956718802452087,0.01975652575492859,0.18457163870334625,positive,0.7759153842926025
32,2012-05-08 05:16:00,"Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin.",0.7777089476585388,0.016997475177049637,0.20529359579086304,positive,0.7607114911079407
33,2012-05-08 05:16:00,The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.,0.07881949096918106,0.006378026679158211,0.9148024916648865,neutral,0.072441466152668
34,2012-05-08 05:16:00,"In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!",0.43368902802467346,0.012674679979681969,0.5536363124847412,neutral,0.42101433873176575
35,2012-05-08 05:16:00,Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518 .,0.02114563062787056,0.01480726059526205,0.9640471339225769,neutral,0.006338370032608509
36,2012-05-08 05:16:00,Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01104306522756815,0.014137434773147106,0.9748194813728333,neutral,-0.0030943695455789566
37,2012-05-08 05:16:00,Disclaimer: Past performance does not guarantee future results.,0.027422117069363594,0.05681845545768738,0.9157593846321106,neutral,-0.029396338388323784
38,2012-05-08 05:16:00,Investors should always research companies and securities before making any investments.,0.044664014130830765,0.00805959664285183,0.9472764134407043,neutral,0.036604419350624084
39,2012-05-08 05:16:00,Nothing herein should be construed as an offer or solicitation to buy or sell any security.,0.018396001309156418,0.0089272977784276,0.972676694393158,neutral,0.009468703530728817
40,2012-05-08 05:16:00,To read this article on Zacks.com click here.,0.01796119473874569,0.0192450862377882,0.9627937078475952,neutral,-0.001283891499042511
41,2012-05-08 05:16:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
